Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA26014J7112· VHA· 260-NETWORK CONTRACT OFFICE 20· 6505 · DRUGS AND BIOLOGICALS· FY2014· $136,064 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

FY14 PROLASTIN C

Base award description: PROLASTIN C

First action · last action
2013-10-01 · 2015-12-11
Transactions
3
First transaction's obligation
$201,600
Base + all options value (sum of deltas)
$136,064
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P13A0002
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$246,400$0Base award · 2013-10-01 · this action $201,600 · running total $201,600Modification P00001 · 2014-02-25 · this action $44,800 · running total $246,400Modification P00002 · 2015-12-11 · this action -$110,336 · running total $136,064
  • Base2013-10-01+$201,600= $201,600
  • Mod P000012014-02-25+$44,800= $246,400
  • Mod P000022015-12-11-$110,336= $136,064
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-01+$201,600$201,600PROLASTIN C
Mod P00001· FUNDING ONLY ACTION2014-02-25+$44,800$246,400FY14 PROLASTIN C
Mod P00002· FUNDING ONLY ACTION2015-12-11−$110,336$136,064FY14 PROLASTIN C

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26016F0697LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20$6,829FY2016
VA26016F0673UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20$8,906FY2016
VA26016J0622SANOFI VACCINES US INC.260-NETWORK CONTRACT OFFICE 20$396,690FY2016
VA26016J0621SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$176,120FY2016
VA26016J0613SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$74,617FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26014J7112_3600_VA797P13A0002_3600 · retrieved 2026-09-26.